For subscribers
Opportunities in S’pore, Asia as venture capital players focus on AI, fintech and healthtech in 2026
Sign up now: Get ST's newsletters delivered to your inbox
Preqin, a provider of data and insights on the alternative assets industry, noted that while fundraising will remain difficult globally, there are signs of recovery in 2026.
ST PHOTO: LIM YAOHUI
- VC firms prioritise AI, fintech, and healthtech in 2026, with 69% focusing on AI, according to Preqin.
- Angelini Ventures sees now as an optimal investment time due to "friendly" valuations. They invested in Singapore's Nuevocor and plan further early-stage opportunities in Singapore.
- Raisewell Ventures advocates for "patient" VC in Southeast Asia, focusing on climatetech, manufacturing, and healthtech.
AI generated
SINGAPORE – The bright spots in venture capital (VC) funding in 2026 will be in the artificial intelligence (AI), fintech and healthtech sectors, industry players said, even as VC firms are finding it tougher to raise funds.
A 2026 report from Preqin, a provider of data and insights on the alternative assets industry, found that VC fund managers view these three areas as their priorities in 2026, with 69 per cent focusing on AI.
